Rhabdomyosarcoma of head and neck varies in aggressiveness depending on the specific site of origin

  • 0Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany; Department of Pediatric Hematology and Oncology, Augustenburger Platz 1, 13353 Berlin, Germany.

|

|

Summary

This summary is machine-generated.

Subsite location significantly impacts head and neck rhabdomyosarcoma outcomes. Orbit, parotid, and ear tumors have better survival, while larynx, oral cavity, and nasal tumors fare worse.

Area Of Science

  • Pediatric Oncology
  • Cancer Research
  • Epidemiology

Background

  • Head and neck rhabdomyosarcoma is a rare pediatric malignancy.
  • Understanding prognostic factors is crucial for treatment stratification.
  • Previous studies have not extensively evaluated granular subsites.

Purpose Of The Study

  • To assess the predictive impact of specific head and neck subsites on rhabdomyosarcoma outcomes.
  • To analyze survival differences across granular subsites in a population-based cohort.
  • To identify distinct biological and clinical characteristics associated with different head and neck subsites.

Main Methods

  • Utilized population-based data from the SEER (Surveillance, Epidemiology, and End Results) program (SEER17) from 2000-2020.
  • Included 1114 newly diagnosed head and neck rhabdomyosarcoma cases across a wide age range (0-90+ years).
  • Employed Kaplan-Meier and Cox regression models to evaluate disease-specific survival (DSS) and overall survival (OS), adjusting for clinical factors.

Main Results

  • Overall 5-year survival rates were 59.1% for OS and 62.4% for DSS.
  • Granular head and neck subsites demonstrated independent predictive impact on survival.
  • Orbit, parotid gland, and ear subsites correlated with better survival, whereas larynx, oral cavity, paranasal sinuses, brain, pharynx, and nose were associated with adverse outcomes.
  • Nasal and paranasal sinus tumors showed distinct aggressive features, including alveolar histology, larger size, distant spread, and higher lymph node involvement.

Conclusions

  • Head and neck rhabdomyosarcoma exhibits significant variability in characteristics and outcomes based on granular subsite.
  • Identifying the prognostic significance of specific subsites is essential for developing risk-adapted treatment strategies.
  • Findings support thorough staging, including pathological lymph node assessment, particularly for nasal and paranasal sinus tumors.